Loading chat...
LA HB112
Bill
Status
3/25/2025
Primary Sponsor
Kathy Edmonston
Click for details
AI Summary
-
Prohibits Louisiana healthcare professional licensing boards and commissions from restricting or banning the prescribing, administering, or dispensing of FDA-approved drugs for off-label uses
-
Defines "off-label use" as using a prescription drug for an indication not approved by the FDA, or using the drug in an unapproved age group, dosage, or route of administration
-
Applies to any drug that has received FDA approval for at least one specific use
-
Enacts new section R.S. 37:1704 under Louisiana's healthcare professional licensing laws
Legislative Description
Provides relative to the prescribing, administering, and dispensing of drugs for off-label use
DRUGS/PRESCRIPTION
Last Action
Read by title, under the rules, referred to the Committee on Health and Welfare.
4/14/2025